ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

CHOP Training Conference Planned

January 23, 1981

Should Be Cut First, DCT Board Says

December 4, 1981

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007

CCI Will Tackle Reimbursement Issue

May 16, 1980

Rauscher Faces Flood Subcommittee, Unfriendly Obey

March 5, 1976